Effect of long-term exposure to combinations of growth promoters in Long Evans rats Part 1.: Endocrine ovarian function

被引:7
作者
Illera, JC [1 ]
Silván, G [1 ]
Martínez-Mateos, MM [1 ]
Blass, A [1 ]
Lorenzo, PL [1 ]
Illera, M [1 ]
机构
[1] Univ Complutense Madrid, Dept Fisiol anim, Fac Vet, E-28040 Madrid, Spain
关键词
growth promoters; clenbuterol; dexamethasone; endocrine ovarian function; progesterone; 17; beta-estradiol; rats; enzyme immunoassay;
D O I
10.1016/S0003-2670(02)01404-6
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The aim of the study was to investigate the effects of long-term exposure (45 days) to growth promoters: clenbuterol (CB; I mg kg(-1) body weight) and/or dexamethasone (DEX; 0.1 mg kg(-1)), in rat endocrine ovarian function and the possibility of recovery after the withdrawal of drug treatment. Animals were sacrificed at different days of withdrawal (W0-W20). Hormone profiles were as follows. Progesterone: CB-treated rats showed significantly lowered plasma (P < 0.01) and elevated ovarian levels until 10 days of withdrawal (P < 0.01); (CB + DEX)-treated rats showed both increased plasma and ovarian levels (P < 0.001); DEX-treated rats showed elevated plasma and lowered ovarian levels during the whole withdrawal. 17beta-Estradiol: CB-treated rats showed significantly elevated plasma until 10 days of withdrawal and lowered ovarian levels during the whole withdrawal (P < 0.001); (CB + DEX)-treated rats showed significantly elevated plasma and lowered ovarian levels during the whole withdrawal (P < 0.001); DEX-treated rats showed increased plasma and ovarian levels (P < 0.001). It was concluded that long-term administration of clenbuterol and/or dexamethasone causes an endocrine ovarian disruption with changes in ovarian steroid secretion. However, after a 20-day withdrawal period, ovarian endocrine function was recovered in CB-treated rats. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 26 条
[1]  
ABE H, 1988, Japanese Journal of Zootechnical Science, V59, P446
[2]  
AGUADO LI, 1982, ENDOCRINOLOGY, V110, P1024
[3]   Activational effects of gonadal steroids on hypothalamo-pituitary-adrenal regulation in the rat disclosed by response to dexamethasone suppression [J].
Almeida, OFX ;
Canoine, V ;
Ali, S ;
Holsboer, F ;
Patchev, VK .
JOURNAL OF NEUROENDOCRINOLOGY, 1997, 9 (02) :129-134
[4]  
[Anonymous], 1992, BMDP STATISTICAL SOFTWARE MANUAL: TO ACCOMPANY BMDP RELEASE 7
[5]  
BEHREND EW, 1997, GLUCOCORTICOID THERA, P187
[6]   INSULIN-LIKE GROWTH FACTOR-I GENE-EXPRESSION BY PRIMARY CULTURES OF OVARIAN-CELLS - INSULIN AND DEXAMETHASONE DEPENDENCE [J].
BOTERO, LF ;
ROBERTS, CT ;
LEROITH, D ;
ADASHI, EY ;
HERNANDEZ, ER .
ENDOCRINOLOGY, 1993, 132 (06) :2703-2708
[7]   THE EFFECT OF CLENBUTEROL SUPPLEMENTATION ON GROWTH-PERFORMANCE AND ON PLASMA-HORMONE AND METABOLITE LEVELS OF BROILERS [J].
BUYSE, J ;
DECUYPERE, E ;
HUYGHEBAERT, G ;
HERREMANS, M .
POULTRY SCIENCE, 1991, 70 (04) :993-1002
[8]   Glucocorticoids inhibit gonadotropin-releasing hormone by acting directly at the hypothalamic level [J].
Calogero, AE ;
Burrello, N ;
Bosboom, AMJ ;
Garofalo, MR ;
Weber, RFA ;
D'Agata, R .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1999, 22 (09) :666-670
[9]  
Cardoso LA, 1996, J ANIM SCI, V74, P2245
[10]   ANABOLIC EFFECTS OF CLENBUTEROL ON SKELETAL-MUSCLE ARE MEDIATED BY BETA(2)-ADRENOCEPTOR ACTIVATION [J].
CHOO, JJ ;
HORAN, MA ;
LITTLE, RA ;
ROTHWELL, NJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (01) :E50-E56